|
Jun 19
|
ABIONYX decides on a capital increase with cancellation of preferential subscription rights for the benefit of a category of persons through the issue of shares with warrants for an amount of c.€3.4 million
|
|
May 16
|
ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the 1st Quarter 2024
|
|
Dec 4
|
ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
|
|
Sep 26
|
ABIONYX Pharma Announces Its 2023 Half-Year Financial Results
|